BioVentrix, Inc. (BVXX)

BioVentrix will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

BioVentrix Financials Overview

Financials in millions usd. Fiscal year is January - December.

Millions usd. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Revenue	0	0	0
Revenue Growth	-	-	-
Operating Income	-6.27	-6.27	-3.56
Net Income	-7.67	-7.67	-3.85

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	1.84	1.84	2.64
Total Debt	8.92	8.92	4.7
Net Cash (Debt)	-7.08	-7.08	-2.06
Net Cash Growth	-	-	-

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-5.81	-5.81	-2.72
Free Cash Flow	-5.81	-5.81	-2.72
Free Cash Flow Growth	-	-	-